Multiple Myeloma10.1007/978-1-4614-8520-9_192013233-244The Role of Radiation Therapy in the Treatment of Multiple Myeloma, Plasmacytoma, and Other Plasma Cell DisordersPrashant Kapoor, James A. Martenson
Radiation Therapy in Hematologic Malignancies10.1007/978-3-319-42615-0_6201685-96Plasmacytoma and Multiple MyelomaRichard Tsang
Advances in Biology and Therapy of Multiple Myeloma10.1007/978-1-4614-4666-8_5201285-95Role of Wnt Signaling Pathways in Multiple Myeloma PathogenesisMariateresa Fulciniti, Daniel R. Carrasco
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2013.05.009201313S349-S354Role of Consolidation/Maintenance Therapy in Multiple MyelomaAntonio Palumbo, Roberto Mina, Chiara Cerrato, Federica Cavallo,
Clinical Lymphoma and Myeloma10.3816/clm.2006.n.03720067133-41Emerging Role of Novel Combinations for Induction Therapy in Multiple MyelomaPeter M. Voorhees, Robert Z. Orlowski,
Resistance to Targeted Therapies in Multiple Myeloma10.1007/978-3-030-73440-4_120211-15The Role of Targeted Therapy in Multiple MyelomaAlice C. Y. Kwok, Silvia CW Ling
Core Evidence10.2147/ce.s60022009215Lenalidomide in multiple myeloma: an evidence-based review of its role in therapyPaul Richardson
Annals of Oncology10.1093/annonc/mdx596.001201728ix15Role of maintenance therapy for multiple myelomaDai Maruyama,,
OncoTargets and Therapy10.2147/ott.s4948020141095Potential role of daratumumab in the treatment of multiple myelomaTomer Mark, Yulian Khagi
Molecular Therapy10.1016/s1525-0016(16)37367-1201119S303-S304794. Enhancing Therapeutic Outcome Using Radiation and Measles Infected CIK Cell Carriers for the Treatment of Disseminated Multiple Myeloma,